CEACAM5 and neoplasm: The pure clinical model (CM), which incorporates four statistically independent clinical predictors—the NLR, CEA level, cT stage, and tumor–pleural relationship—demonstrated the baseline predictive efficacy, with an AUC value of 0.761 in the training cohort and 0.732 in the validation cohort.